248 related articles for article (PubMed ID: 18616417)
1. Inflammatory lipids as a target for therapy in the rheumatic diseases.
McMahon M; Brahn E
Expert Opin Investig Drugs; 2008 Aug; 17(8):1213-24. PubMed ID: 18616417
[TBL] [Abstract][Full Text] [Related]
2. Statins: immunomodulators for autoimmune rheumatic disease?
Jury EC; Ehrenstein MR
Lupus; 2005; 14(3):192-6. PubMed ID: 15807195
[TBL] [Abstract][Full Text] [Related]
3. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia.
Hahn BH; Grossman J; Chen W; McMahon M
J Autoimmun; 2007; 28(2-3):69-75. PubMed ID: 17433865
[TBL] [Abstract][Full Text] [Related]
4. Vaccination, atherosclerosis and systemic lupus erythematosus.
Carvalho JF; Pereira RM; Shoenfeld Y
Lupus; 2009 Nov; 18(13):1209-12. PubMed ID: 19880570
[TBL] [Abstract][Full Text] [Related]
5. Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association.
McMahon M; Hahn BH
Curr Opin Immunol; 2007 Dec; 19(6):633-9. PubMed ID: 18083018
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular co-morbidity in rheumatic diseases.
Turesson C; Jacobsson LT; Matteson EL
Vasc Health Risk Manag; 2008; 4(3):605-14. PubMed ID: 18827910
[TBL] [Abstract][Full Text] [Related]
7. Dual effects of statins therapy in systemic lupus erythematosus and SLE-related atherosclerosis: the potential role for regulatory T cells.
Tu H; Li Q; Xiang S; Jiang H; Mao Y; Shou Z; Chen J
Atherosclerosis; 2012 May; 222(1):29-33. PubMed ID: 22417842
[TBL] [Abstract][Full Text] [Related]
8. Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment.
Ruiz-Limon P; Barbarroja N; Perez-Sanchez C; Aguirre MA; Bertolaccini ML; Khamashta MA; Rodriguez-Ariza A; Almadén Y; Segui P; Khraiwesh H; Gonzalez-Reyes JA; Villalba JM; Collantes-Estevez E; Cuadrado MJ; Lopez-Pedrera C
Ann Rheum Dis; 2015 Jul; 74(7):1450-8. PubMed ID: 24658835
[TBL] [Abstract][Full Text] [Related]
9. Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies.
Hahn BH; McMahon M
Lupus; 2008 May; 17(5):368-70. PubMed ID: 18490409
[TBL] [Abstract][Full Text] [Related]
10. Atherosclerosis in systemic lupus erythematosus.
Sherer Y; Zinger H; Shoenfeld Y
Autoimmunity; 2010 Feb; 43(1):98-102. PubMed ID: 20014976
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.
Zinger H; Sherer Y; Shoenfeld Y
Clin Rev Allergy Immunol; 2009 Aug; 37(1):20-8. PubMed ID: 18991025
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis.
Sherman CB; Peterson SJ; Frishman WH
Cardiol Rev; 2010; 18(3):141-7. PubMed ID: 20395699
[TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction in rheumatic autoimmune diseases.
Murdaca G; Colombo BM; Cagnati P; Gulli R; Spanò F; Puppo F
Atherosclerosis; 2012 Oct; 224(2):309-17. PubMed ID: 22673743
[TBL] [Abstract][Full Text] [Related]
14. Therapy with statins in patients with refractory rheumatic diseases: a preliminary study.
Abud-Mendoza C; de la Fuente H; Cuevas-Orta E; Baranda L; Cruz-Rizo J; González-Amaro R
Lupus; 2003; 12(8):607-11. PubMed ID: 12945719
[TBL] [Abstract][Full Text] [Related]
15. Dyslipidemia in systemic lupus erythematosus.
Szabó MZ; Szodoray P; Kiss E
Immunol Res; 2017 Apr; 65(2):543-550. PubMed ID: 28168401
[TBL] [Abstract][Full Text] [Related]
16. Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?
Molloy ES; Calabrese LH
Autoimmun Rev; 2008 Dec; 8(2):144-6. PubMed ID: 18700172
[TBL] [Abstract][Full Text] [Related]
17. [Statins--are they potentially useful in rheumatology?].
Bielinska A; Gluszko P
Pol Arch Med Wewn; 2007 Sep; 117(9):420-5. PubMed ID: 18062565
[TBL] [Abstract][Full Text] [Related]
18. Cardiorheumatology: cardiac involvement in systemic rheumatic disease.
Prasad M; Hermann J; Gabriel SE; Weyand CM; Mulvagh S; Mankad R; Oh JK; Matteson EL; Lerman A
Nat Rev Cardiol; 2015 Mar; 12(3):168-76. PubMed ID: 25533796
[TBL] [Abstract][Full Text] [Related]
19. The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases.
Gasparyan AY; Stavropoulos-Kalinoglou A; Mikhailidis DP; Toms TE; Douglas KM; Kitas GD
Curr Vasc Pharmacol; 2010 Jul; 8(4):437-49. PubMed ID: 19758114
[TBL] [Abstract][Full Text] [Related]
20. Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders.
Suciu CF; Prete M; Ruscitti P; Favoino E; Giacomelli R; Perosa F
Autoimmun Rev; 2018 Apr; 17(4):366-375. PubMed ID: 29425936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
